Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 2008, p. 6208-6222, Vol. 28, No. 20
0270-7306/08/$08.00+0 doi:10.1128/MCB.00611-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
B and of NF-
B-Mediated De Novo Synthesis of IRF-1
Molecular and Cellular Biology Laboratory,1 Laboratory of Biochemistry, Division of Basic Sciences, University of Crete Medical School, Heraklion, Crete, Greece,2 Institute for Molecular Biology and Biotechnology, Foundation of Research and Technology Hellas, Heraklion, Crete, Greece3
Received 16 April 2008/ Returned for modification 8 May 2008/ Accepted 30 July 2008
Cancer cells may evade immune surveillance as a result of defective antigen processing and presentation. In this study, we demonstrate that CD40 ligation overcomes this defect through the coordinated action of the transcription factors NF-
B and interferon regulatory factor 1 (IRF-1). We show that unlike interferon signaling, which triggers the STAT1-mediated transcriptional activation of IRF-1, the ligation of CD40 in carcinomas induces the rapid upregulation of IRF-1 in a STAT1-independent but NF-
B-dependent manner. The transcriptional activation of IRF-1 is controlled largely by the recruitment of p65 (RelA) NF-
B to the IRF-1 promoter following the engagement of a TAK1/I
B kinase β/I
B
signaling pathway downstream of CD40. NF-
B and de novo-synthesized IRF-1 converge to regulate the expression of genes involved in antigen processing and transport, as evident from the sequential recruitment of NF-
B and IRF-1 to the promoters of the genes encoding transporter for antigen processing 1 (TAP1), TAP2, tapasin, and low-molecular-mass polypeptides LMP2 and LMP10. Moreover, the RNA interference-mediated knockdown of IRF-1 reduced, whereas the inhibition of NF-
B abolished, the effects of CD40 on TAP1 and LMP2 upregulation in carcinoma cells. Collectively, these data reveal a novel "feed-forward" mechanism induced by NF-
B which ensures that acutely synthesized IRF-1 operates in concert with NF-
B to amplify the immunoproteasome and antigen-processing functions of CD40.
Published ahead of print on 11 August 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»